ES548013A0 - Procedimiento para la obtencion de derivados de piridina - Google Patents

Procedimiento para la obtencion de derivados de piridina

Info

Publication number
ES548013A0
ES548013A0 ES548013A ES548013A ES548013A0 ES 548013 A0 ES548013 A0 ES 548013A0 ES 548013 A ES548013 A ES 548013A ES 548013 A ES548013 A ES 548013A ES 548013 A0 ES548013 A0 ES 548013A0
Authority
ES
Spain
Prior art keywords
procedure
obtaining
actions
alkyl
piridine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES548013A
Other languages
English (en)
Other versions
ES8704478A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES548013A0 publication Critical patent/ES548013A0/es
Publication of ES8704478A1 publication Critical patent/ES8704478A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Automatic Cycles, And Cycles In General (AREA)
ES548013A 1984-10-19 1985-10-18 Procedimiento para la obtencion de derivados de piridina Expired ES8704478A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843438394 DE3438394A1 (de) 1984-10-19 1984-10-19 Pyridinderivate

Publications (2)

Publication Number Publication Date
ES548013A0 true ES548013A0 (es) 1987-04-01
ES8704478A1 ES8704478A1 (es) 1987-04-01

Family

ID=6248339

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548013A Expired ES8704478A1 (es) 1984-10-19 1985-10-18 Procedimiento para la obtencion de derivados de piridina

Country Status (10)

Country Link
US (2) US4665187A (es)
EP (1) EP0180794B1 (es)
JP (1) JPS61100579A (es)
AT (1) ATE43591T1 (es)
AU (1) AU583308B2 (es)
CA (1) CA1269384A (es)
DE (2) DE3438394A1 (es)
ES (1) ES8704478A1 (es)
HU (1) HU195652B (es)
ZA (1) ZA858041B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3609142A1 (de) * 1986-03-19 1987-09-24 Merck Patent Gmbh Pyridinderivate
US5118691A (en) * 1990-09-20 1992-06-02 Warner-Lambert Co. Substituted tetrahydropyridines as central nervous system agents
US5045550A (en) * 1990-09-20 1991-09-03 Warner-Lambert Co. Substituted tetrahydropyridines as central nervous system agents
US5187280A (en) * 1990-09-20 1993-02-16 Warner-Lambert Company Substituted tetrahydropyridines and their use as central nervous system agents
DE19612890C2 (de) * 1996-03-30 2003-12-18 Diehl Stiftung & Co Mörsergeschoß
CA2398388A1 (en) 2000-01-20 2001-07-26 Koji Kato Novel piperidine compound and pharmaceutical thereof
EP1724253A3 (en) * 2005-05-10 2009-11-04 Ajinomoto Co., Inc. Production method of optically active diphenylalanine compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125488A (en) * 1964-03-17 Method of inducing analgesia by
US3546236A (en) * 1968-10-15 1970-12-08 Smithkline Corp 1 - (benzoheterocyclic cyclopropylmethyl) - 4 - phenyl - 1,2,5,6 - tetrahydropyridines
FR2501682A1 (fr) * 1981-03-11 1982-09-17 Sanofi Sa Trifluoromethylphenylpyridines a activite anorexigene, un procede de preparation et compositions pharmaceutiques en contenant
FR2501506A1 (fr) * 1981-03-11 1982-09-17 Sanofi Sa Compositions pharmaceutiques a action anorexigene contenant des derives de la tetrahydropyridine
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques

Also Published As

Publication number Publication date
ATE43591T1 (de) 1989-06-15
AU583308B2 (en) 1989-04-27
ZA858041B (en) 1986-06-25
HU195652B (en) 1988-06-28
EP0180794B1 (de) 1989-05-31
DE3570668D1 (en) 1989-07-06
US4665187A (en) 1987-05-12
CA1269384A (en) 1990-05-22
DE3438394A1 (de) 1986-04-30
EP0180794A1 (de) 1986-05-14
JPS61100579A (ja) 1986-05-19
US4760082A (en) 1988-07-26
HUT39741A (en) 1986-10-29
ES8704478A1 (es) 1987-04-01
AU4873785A (en) 1986-04-24

Similar Documents

Publication Publication Date Title
ES548455A0 (es) Procedimiento para la preparacion de nuevos derivados de pi-colina
OA07809A (fr) Dérivés de la 1-hétéroaryl-4-/(2,5-pyrrolidinedion-1-yl) alkyl/ pipérazine.
SE7907121L (sv) Ftalimidinderivat
SE8302693L (sv) Heterocykliska foreningar
AU2058283A (en) 2-amino-3-acylamino-6-benzylamino pyridine derivatives
ES494791A0 (es) Procedimiento para la preparacion de acidos oxirancarboxili-cos sustituidos
AR225884A1 (es) Procedimiento para producir nuevos derivados de 1,4-bis(aminoalquil(c2-c4)amino)antraquinosas
PT82945B (pt) Processo para a preparacao de novos derivados de 2,3-dihidro-benzofurano
DE3683922D1 (de) Chinolinderivate.
ES548013A0 (es) Procedimiento para la obtencion de derivados de piridina
ES514340A0 (es) "procedimiento de obtencion de nuevos derivados de piperazina".
DK224281A (da) Fremgangsmaade til fremstilling af 2,2-dimethylpenam-3-carboxylsyre-1,1-dioxid-forbindelser eller salte deraf
AR240924A1 (es) "procedimiento para preparar derivados de 1,3-oxazolidin-2-ona y sus sales".
MX7122E (es) Procedimiento para la preparacion de derivados de tiometilpiridina
AR227542A1 (es) Procedimiento para preparar derivados de 4-(4-amino-6,7-dimetoxi-quinazolin-2-il)-1-(2,4-dioxo-2,2,3,4-tetrahidro-pirimidin-6-il)-piperazina
AR231134A1 (es) Procedimiento para obtener derivados de 4-(sulfamoilfenil)-2-(hidroxi-o aciloxi-fenilimino)-tiazolina
DK447284A (da) Aminoderivater af 2-(n-(2,2,5,5-tetramethyl-3-pyrrolin-3-carbonyl)),deres fremstilling og anvendelse
MX5446E (es) Procedimiento para la preparacion de derivados de 2-(fenoxi-alquilo)-2-imidazolinas substituidas por 1-iminometileno
SE7609222L (sv) Alkylsulfonylaminosubstituerade heterocykler
SE8503225D0 (sv) Diacyloxi-1,8-acyl-10-antroner, sett for deras framstellning och deras anvendning som lekemedel for djur och menniska samt for kosmetika
ES493591A0 (es) Procedimiento para la preparacion de derivados de 4-(nafta- leniloxi)piperidina
AR228852A1 (es) Procedimiento para preparar derivados de 1,1'bifenil-2-il-alquilamina y sus sales
FI855132A0 (fi) 2,3-diamino-2,3 -didesoxyhexosderivat, foerfarande foer deras framstaellning och deras anvaendning.
ES523379A0 (es) Procedimiento para la obtencion de un derivado de organofosfato.
AR240935A1 (es) Procedimiento para preparar compuestos de 3-amino-4 2-(2-guanidinotiazol-4-il)-alquiltio) alquilamino-1,2,5-tiadiazol y sus sales.

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506